HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.

about

Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection.Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study.

P2860

Q47572592-364B449F-0BDF-4890-98B3-11A51B3D9C06 Q55056866-DABAC576-0CB2-466C-9EF7-FDEEBEEFDD2F

P2860

HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.

Item

http://www.wikidata.org/entity/Q38733664

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

HIV-coinfected patients respon ...... s: a prospective cohort study.

@en

type

Item

label

HIV-coinfected patients respon ...... s: a prospective cohort study.

@en

prefLabel

HIV-coinfected patients respon ...... s: a prospective cohort study.

@en

P1476

HIV-coinfected patients respon ...... ls: a prospective cohort study

@en

P2093

Antonio Collado

http://www.w3.org/2001/XMLSchema#string

Francisco Vera-Méndez

http://www.w3.org/2001/XMLSchema#string

Ignacio de Los Santos-Gil

http://www.w3.org/2001/XMLSchema#string

Marta Montero-Alonso

http://www.w3.org/2001/XMLSchema#string

Marta Suárez-Santamaría

http://www.w3.org/2001/XMLSchema#string

María J Ríos

http://www.w3.org/2001/XMLSchema#string

María Mancebo

http://www.w3.org/2001/XMLSchema#string

Paloma Geijo-Martínez

http://www.w3.org/2001/XMLSchema#string

Rafael Granados

http://www.w3.org/2001/XMLSchema#string

Sergio Reus-Bañuls

http://www.w3.org/2001/XMLSchema#string

P2860

Telaprevir for previously untreated chronic hepatitis C virus infection

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Boceprevir for untreated chronic HCV genotype 1 infection

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

Classification of chronic viral hepatitis: a need for reassessment.

Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.

P304

126-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15284336.2017.1330801

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karin Neukam

Juan A. Pineda

Francisco Téllez

Antonio Rivero-Juarez

Luis Enrique Morano Amado

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28599618

http://www.w3.org/2001/XMLSchema#string

HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.

about

P2860

P2860

HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698